Frost & Sullivan Lauds CleveMed for Kinesia(TM), a Revolutionary Mobility Disorder Monitoring System.PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif. -- Based on its recent analysis of the mobility disorder monitoring systems market, Frost & Sullivan recognizes Cleveland Medical Devices Inc. (CleveMed) with the 2008 North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. Product Innovation of the Year Award. This Award highlights CleveMed's development of Kinesia[TM], a quantitative motor assessment system for monitoring the upper extremity upper extremity n. The shoulder, arm, forearm, wrist, or hand. Also called superior limb, thoracic limb. motor symptoms of movement disorders Movement Disorders Definition Movement disorders are a group of diseases and syndromes affecting the ability to produce and control movement. Description , such as Parkinson's disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. and essential tremor Essential tremor An uncontrollable (involuntary) shaking of the hands, head, and face. Also called familial tremor because it is sometimes inherited, it can begin in the teens or in middle age. The exact cause is not known. . The device, worn on the wrist and finger of the patient, monitors three dimensional motion and electrical muscle activity and can be used to quantify the severity of movement disorder List of Movement disorders
"As a product, Kinesia represents a unique and unprecedented approach to unifying diagnostic and sensing technology to monitor mobility disorders," says Frost & Sullivan Research Analyst Abhishek Dutta. "By doing so, the device further provides a standardized platform to facilitate efficient neurodiagnostic monitoring of the disease or disorder." Currently, subjective rating scales are used by clinicians to rate movement disorder symptom severity which can cause high variability in assessment. A clinician can use Kinesia along with these rating scales as a standardized platform to compare changes in symptoms from visit to visit, helping to minimize the variability in clinical assessment. The device can also be used in a home monitoring application which would provide clinicians the opportunity to view symptom fluctuations in a more continuous fashion, allowing optimization of patient medication timing and dosage. In addition, Kinesia is suited for pharmaceutical drug development and efficacy trials as well as evaluating deep brain stimulation In neurotechnology, deep brain stimulation (DBS) is a surgical treatment involving the implantation of a medical device called a brain pacemaker, which sends electrical impulses to specific parts of the brain. as a treatment for movement disorder symptoms. "We are honored to accept this award from Frost & Sullivan. It punctuates the large clinical market need for technology to quantify and track movement disorders motor symptoms in light of rapidly expanding research and treatment modalities," said Joseph P. Giuffrida, PhD, Director of CleveMed's Division of Movement Disorders. "Kinesia is being developed as a standardized platform to measure motor symptoms. Our goal is that this technology will ultimately benefit the large population affected by diseases such as Parkinson's and essential tremor." The technology used to create Kinesia is unique from other motion monitoring devices currently on the market such as actigraphy devices and tremor monitors. While these technologies use limited sensing technology, Kinesia allows a clinician to monitor the natural three-dimensional movements and rotations of the upper extremity. It is the first device of its kind to include accelerometers, gyroscopes and electromyography electromyography Process of graphically recording the electrical activity of muscle, which normally generates an electric current only when contracting or when its nerve is stimulated. (EMG EMG abbr. electromyogram Electromyography (EMG) A diagnostic test that records the electrical activity of muscles. ) capability in a wireless device that weighs less than a quarter pound and is smaller than a deck of cards. Comprised of two compact, patient-worn components - the Finger Sensor and the Wrist Module - the Kinesia system allows for objective and continuous monitoring of movement disorder symptoms without sacrificing size, portability and comfort. The Finger Sensor houses the motion sensors while the Wrist Module incorporates a Bluetooth([R]) radio for wireless data transmission, a memory card that stores up to 12 hours of data and an optional input for two channels of EMG. Also a part of the Wrist Module is a push-button (electronics) push-button - A roughly fingertip-sized plastic cover attached to a spring-loaded, normally-open switch, which, when pressed, closes the switch. Typical examples are the keys on a computer or calculator keyboard and mouse buttons. patient diary A Patient Diary is a tool used during a clinical trial or a disease treatment to measure treatment compliance. An Electronic Patient Diary registers the diary in a storage device and allows for monitoring the time the medication was taken. for tracking medication times and symptom fluctuations. The unit wirelessly transmits data to a computer where it can be displayed, stored and analyzed. Included in the Kinesia software is a database of automated upper extremity tasks. In this section, patients are guided by video through a series of evaluation tasks normally completed during a movement disorder exam. Data is then saved behind the scenes for later review and analysis. This can be useful for in-clinic exams, home use or automating pharmaceutical trials. Kinesia is poised to greatly improve the monitoring of movement disorder symptoms. The industry is by and large going to hugely benefit from this innovative product as this proprietary compact, noninvasive, wireless and wearable patient monitoring system aids in quantifying the severity of movement disorder symptoms. In recognition of the novel technical capabilities and innovative unique features of the Kinesia system, Frost & Sullivan presents the 2008 Product Innovation of the Year Award to CleveMed. Each year, Frost & Sullivan presents this Award to the company that has demonstrated excellence in new products and technologies within its industry. The recipient company has shown innovation by launching a broad line of emerging products and technologies. Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry. About CleveMed CleveMed was founded with the goal of developing innovative telemetry telemetry Highly automated communications process by which data are collected from instruments located at remote or inaccessible points and transmitted to receiving equipment for measurement, monitoring, display, and recording. devices for a variety of medical applications. Today, CleveMed is developing and pioneering the use of novel wireless monitoring systems for high growth neurology and rehabilitation applications, including movement disorders, sleep disorders Sleep Disorders Definition Sleep disorders are a group of syndromes characterized by disturbance in the patient's amount of sleep, quality or timing of sleep, or in behaviors or physiological conditions associated with sleep. and brain monitoring. Through these innovations, CleveMed has developed a growing range of products that address the needs of the medical, research and academic communities. For more information, please visit www.CleveMed.com. Kinesia was developed through support provided by Small Business Innovation Research grants from the National Institutes of Health, National Institute of Neurological Disorders and Stroke The National Institute of Neurological Disorders and Stroke is a part of the U.S. National Institutes of Health. The NINDS conducts and supports research on brain and nervous system disorders. Created by the U.S. and commercialized with support provided by the Ohio Research Commercialization Grant Program from the State of Ohio. About Frost & Sullivan Frost & Sullivan, the Global Growth Consulting Company Noun 1. consulting company - a firm of experts providing professional advice to an organization for a fee consulting firm business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a , partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents Six Continents is a large retail PLC in UK which split into Six Continents Retail known as Mitchells and Butlers plc. The hotels and soft drinks business of Six Continents PLC is now known as InterContinental Hotels Group PLC. . For more information about Frost & Sullivan's Growth Partnerships, visit http://www.awards.frost.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion